Updated Oct 9, 2026 · 04:30 UTC
JNJJohnson & Johnson
Health Care · United States · XNYS · pharmaceutical preparations
$255.08−0.76%last session · market closed
Market cap
$614.70b
real-world
Tokenized
$602k
<0.001% of the asset
Avg token price
$261.90
+2.68% vs real
Spot volume, 24h
$188k
5 venues
Derivatives, 24h
$2.9m
0.2% of real volume
Perp open interest
$1.5m
10 venues
In DeFi
—
JNJ · Price
Oct 24, 2025low $184.20 · high $278.78 · now $255.55Oct 7, 2026
Token Real
Earnings
Nasdaq’s earnings calendar
Next earnings
Oct 13
before the open · Sep 2026 quarter · EPS forecast $2.82 (7 analysts)
Last earnings, Jul 15
$2.90 EPS
+2.1% vs $2.84 forecast · Jun 2026 quarter
Real market
Johnson & Johnson
Last close
$258.45
Oct 7
Traded on Oct 7
$1.40b
Price now
$255.08
market closed
Where it trades
24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · $188k · 5 venues
OKX1 pair$102k
Blynex1 pair$87k
Kraken1 pair$29Derivatives · $2.9m · 10 venues · $1.5m open interest
BingX1 pair · OI $986k · funding +0.0050%$1.7m
Bybit1 pair · OI $156k · funding +0.0000%$496kOKX1 pair · OI $167k · funding +0.0000%$295kOnchain versions
4 tokens from 3 issuers
JNJXBacked Assets$256.94$577k
WJNJXBacked Assets$262.18$15k
JNJonOndo Assets$268.17$10k
JNJ.DDinari Assetstied here——By chain
Where the tokens circulate, issuers’ unsold stock taken off
Solana62%$374k
TON29%$177k
Ethereum3.4%$20k
X Layer2.5%$15k
Ink2.0%$12k
BNB Chain0.6%$3kIn DeFi
Pools and lending markets that hold these tokens
None found
Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$97.93b
+8% YoY
Net income
$21.04b
21% margin · −7% YoY
EPS, diluted
$8.62
−8% YoY
Gross margin
68%
Cash and balance sheet
Free cash flow
$22.24b
23% of revenue
Net debt
$28.28b
$20.76b cash and securities, $49.04b debt
Diluted shares
2.44b
+1% YoY
Valuation at today’s market cap
P/E
29×
EV / sales
6.6×
enterprise value $642.98b
Free cash flow yield
3.6%
Quarterly
RevenueNet income